Related Experiment Video
Updated: Aug 14, 2026

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
Caspase-3 activation and induction of PARP cleavage by cyclic dipeptide cyclo(Phe-Pro) in HT-29 cells
Seth Clint Brauns1, Gill Dealtry, Pieter Milne
1Department of Biochemistry and Microbiology, Nelson Mandela Metropolitan University, Port Elizabeth, 6031, South Africa.
Background:
Cyclo(Phe-Pro) has been shown to inhibit cancer cell growth and induce apoptosis in HT-29 colon cancer cells.
Materials And Methods:
The molecular mechanisms mediating cyclo(Phe-Pro)-induced apoptosis in HT-29 cells were investigated. Cells were treated with 5 mM or 10 mM cyclo(Phe-Pro) for varying times. Immunoblot analysis was used to detect poly(ADP-ribose)polymerase (PARP) cleavage. A fluorescence-based enzymatic assay was used to measure caspase-3 activity.
Results:
Cyclo(Phe-Pro) (10 mM) induced time-dependent cleavage of PARP, detected as early as 8 hours post treatment. PARP cleavage was blocked by co-administration with the broad-range caspase inhibitor Z-VAD-FMK Cyclo(Phe-Pro) also induced a time-dependent increase (p < 0.01) in caspase-3 activity. This increase in activity was blocked in the presence of the caspase-3 inhibitor Ac-DEVD-CHO.
Conclusion:
These results provide evidence that cyclo(Phe-Pro)-induced apoptosis in HT-29 cells is mediated by a caspase cascade. These findings warrant further investigation into the potential antitumour activity of cyclo(Phe-Pro) and its related cyclic dipeptide derivatives.
Insights
Cyclo(Phe-Pro) triggers programmed cell death (apoptosis) in colon cancer cells by activating caspases, a key signaling pathway. This research highlights cyclo(Phe-Pro) as a potential anti-cancer agent.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Cyclo(Phe-Pro) demonstrates anti-cancer properties, inhibiting growth and inducing apoptosis in HT-29 colon cancer cells.
- Understanding the precise molecular pathways is crucial for therapeutic development.
Purpose of the Study:
- To elucidate the molecular mechanisms behind cyclo(Phe-Pro)-induced apoptosis in HT-29 colon cancer cells.
- To investigate the role of caspases in this process.
Main Methods:
- HT-29 cells were treated with varying concentrations and durations of cyclo(Phe-Pro).
- Poly(ADP-ribose)polymerase (PARP) cleavage was assessed using immunoblot analysis.
- Caspase-3 activity was measured via a fluorescence-based enzymatic assay.
- Inhibitors of caspases (Z-VAD-FMK and Ac-DEVD-CHO) were used to confirm pathway involvement.
Main Results:
- Cyclo(Phe-Pro) induced time-dependent PARP cleavage, a hallmark of apoptosis, starting at 8 hours.
- This PARP cleavage was abrogated by a broad-range caspase inhibitor.
- A significant, time-dependent increase in caspase-3 activity was observed.
- The caspase-3 activation was specifically blocked by a caspase-3 inhibitor.
Conclusions:
- Cyclo(Phe-Pro) induces apoptosis in HT-29 colon cancer cells through a caspase-dependent signaling cascade.
- These findings support further research into cyclo(Phe-Pro) and related cyclic dipeptides as potential anti-cancer therapeutics.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
The Extrinsic Apoptotic Pathway
Anaphase Promoting Complex

